| Record ID | marc_records_scriblio_net/part17.dat:76357215:1468 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part17.dat:76357215:1468?format=raw |
LEADER: 01468pam 2200313 a 4500
001 84071408
003 DLC
005 19841127000000.0
008 840813s1984 dcua b 10000 eng
010 $a 84071408
020 $a091733051X :$c$39.00 ($26.00 APhA members)
050 1 $aRA1238$b.E96 1984
060 $aQV 771 E96 1982
082 0 $a615.9$219
245 00 $aExperimental and clinical toxicokinetics /$cedited by Avraham Yacobi and Herbert Barry, III.
260 0 $aWashington, DC :$bAmerican Pharmaceutical Association, Academy of Pharmaceutical Sciences,$cc1984.
300 $axvi, 188 p. :$bill. ;$c24 cm.
500 $a"Based on a symposium sponsored by the APhA Academy of Pharmaceutical Sciences, Section on Pharmacodynamics and Drug Disposition of the American Pharmaceutical Association at the 33rd National Meeting, November 1982, San Diego, California"--T.p. verso.
504 $aIncludes bibliographical references.
650 0 $aDrugs$xToxicology$xCongresses.
650 0 $aPharmacokinetics$xCongresses.
650 2 $aDrug Evaluation$xcongresses.
650 2 $aDrug Screening$xcongresses.
650 2 $aDrugs$xtoxicity$xcongresses.
650 2 $aKinetics$xcongresses.
700 10 $aYacobi, Avraham.
700 10 $aBarry, Herbert,$d1930-
710 20 $aAcademy of Pharmaceutical Sciences.$bSection on Pharmacodynamics and Drug Disposition.
710 20 $aAcademy of Pharmaceutical Sciences.$bNational Meeting$n(33rd :$d1982 :$cSan Diego, Calif.)